MedPath

NOVA 7037 - LIQ

NOVA 7037 - LIQ

Discontinued
DIN Number

02121654

Drug Class

Human

Market Date

Feb 21, 1995

Company
HC

nova homeopathic therapeutics inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02121654
AIG Number1026630001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (10)

BELLADONNAActive
Strength: 12 X / ML
Monograph: BELLADONNA
CALCIUM CARBONATEActive
Strength: 12 X / ML
Monograph: CALCIUM CARBONATE
CINCHONA OFFICINALISActive
Strength: 6 X / ML
Monograph: CINCHONA OFFICINALIS
NITROGLYCERINActive
Strength: 8 X / ML
Monograph: NITROGLYCERIN
PLATINUMActive
Strength: 10 X / ML
Monograph: PLATINUM
PULSATILLAActive
Strength: 12 X / ML
Monograph: PULSATILLA
SANGUINARIA CANADENSISActive
Strength: 6 X / ML
Monograph: SANGUINARIA CANADENSIS
SULFURActive
Strength: 12 X / ML
Monograph: SULFUR
TIGER LILYActive
Strength: 6 X / ML
Monograph: TIGER LILY
TINActive
Strength: 8 X / ML
Monograph: TIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.